Adverse events338

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 338

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Platelet count decreased	Investigations	Belantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)	23	30	94
other	Platelet count decreased	Investigations	Daratumumab + Bor + Dex	27	40	79
other	White blood cell count decreased	Investigations	Belantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)	16	30	52
other	White blood cell count decreased	Investigations	Daratumumab + Bor + Dex	26	40	93
other	Alanine aminotransferase increased	Investigations	Belantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)	19	30	45
other	Alanine aminotransferase increased	Investigations	Daratumumab + Bor + Dex	19	40	34
other	Aspartate aminotransferase increased	Investigations	Belantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)	20	30	79
other	Aspartate aminotransferase increased	Investigations	Daratumumab + Bor + Dex	15	40	29
other	Lymphocyte count decreased	Investigations	Belantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)	13	30	57
other	Lymphocyte count decreased	Investigations	Daratumumab + Bor + Dex	22	40	78
other	Neutrophil count decreased	Investigations	Belantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)	14	30	40
other	Neutrophil count decreased	Investigations	Daratumumab + Bor + Dex	20	40	58
other	Gamma-glutamyltransferase increased	Investigations	Belantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)	12	30	21
other	Gamma-glutamyltransferase increased	Investigations	Daratumumab + Bor + Dex	9	40	17
other	Blood lactate dehydrogenase increased	Investigations	Belantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)	11	30	33
other	Blood lactate dehydrogenase increased	Investigations	Daratumumab + Bor + Dex	5	40	15
other	Weight decreased	Investigations	Belantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)	7	30	9
other	Weight decreased	Investigations	Daratumumab + Bor + Dex	7	40	11
other	Blood bilirubin increased	Investigations	Belantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)	5	30	8
other	Blood bilirubin increased	Investigations	Daratumumab + Bor + Dex	6	40	16

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06868654/events

API reference For AI assistants

Adverse events338

Sources 3

Read this list from software.